Skip to content

Depression: all studies

Page 688 of 1,034: studies 6,871 to 6,880 of 10,336, newest first. Back to the depression overview

Research

Impact of a Stress Reduction, Meditation, and Mindfulness Program in Patients with Chronic Heart Failure: A Randomized Controlled Trial.

Arquivos brasileiros de cardiologia October 1, 2023 Vaisnava Nogueira Cavalcante, Evandro Tinoco Mesquita, Ana Carla Dantas Cavalcanti et al. 9 citations

Heart Failure is a significant public health problem leading to a high burden of physical and psychological symptoms despite optimized therapy. To evaluate primarily the impact of a Stress Reduction, Meditation, and Mindfulness Program on stress reduction of patients with Heart Failure. A randomized and controlled clinical trial assessed the effect of a stress reduction program compared to...

Psychedelic-Assisted Therapy in Military and Veterans Healthcare Systems: Clinical, Legal, and Implementation Considerations.

Current Psychiatry Reports October 1, 2023 Aaron Wolfgang, Charles W Hoge 15 citations

This review discusses the current and projected landscape of psychedelic-assisted therapy (PAT), with a focus on clinical, legal, and implementation considerations in Department of Defense (DoD) and Department of Veterans Affairs (VA) healthcare systems. 3,4-Methylenedioxymethamphetamine (MDMA)- and psilocybin-assisted therapy have shown promising outcomes in efficacy, safety, tolerability, and...

Emerging Medical Use of Psychedelics

Korean Academy of Addiction Psychiatry September 30, 2023 Seon Young Park, Ung Gu Kang

Psychedelic drugs, once classified as prohibited drugs, have recently regained attention as medicinal drugs. It is anticipated that psychedelic drugs will show effectiveness for various psychiatric symptoms due to their mind-altering actions. Currently, clinical trials are being conducted to evaluate the therapeutic effects on end-of-life care, depressive disorder, anxiety disorder,...

Musical hallucinations, secondary delusions, and lack of insight: results from a cohort study

Frontiers in Psychiatry September 28, 2023 Milou A. Buijk, R. F. Lauw, Jan Adriaan Coebergh et al. 3 citations

Introduction Although musical hallucinations do not tend to be accompanied by delusions, occasionally patients persistently accuse others of being responsible for causing the music they perceive, sometimes with severe social consequences such as frequently calling the police or moving house. In this study we seek to broaden our understanding of this rare type of musical hallucination that comes...

Activation of σ1-Receptors by R-Ketamine May Enhance the Antidepressant Effect of S-Ketamine

Biomedicines September 28, 2023 Hans O. Kalkman 8 citations

Ketamine is a racemic mixture composed of two enantiomers, S-ketamine and R-ketamine. In preclinical studies, both enantiomers have exhibited antidepressant effects, but these effects are attributed to distinct pharmacological activities. The S-enantiomer acts as an NMDA-channel blocker and as an opioid μ-receptor agonist, whereas the R-enantiomer binds to σ1-receptors and is believed to act as...

Experiences of Using Digital Mindfulness-Based Interventions: Rapid Scoping Review and Thematic Synthesis.

Journal of Medical Internet Research September 28, 2023 Emma Louise Osborne, Ben Ainsworth, Nic Hooper et al. 28 citations

Digital mindfulness-based interventions (MBIs) are a promising approach to deliver accessible and scalable mindfulness training and have been shown to improve a range of health outcomes. However, the success of digital MBIs is reliant on adequate engagement, which remains a crucial challenge. Understanding people's experiences of using digital MBIs and identifying the core factors that...

Analyzing the Influence of Mindfulness-Based Interventions on Mental Health: A Citation-Based Approach

West Science Interdisciplinary Studies September 27, 2023 Fitriah Handayani, Jane Mariem Monepa, Ria Sulistiana et al.

In recent years, mindfulness-based interventions, or MBIs, have drawn a lot of attention as a potentially effective strategy for enhancing mental health and wellbeing. In order to perform a bibliometric analysis of the literature on mental health and MBIs, this study looked at collaborative networks, prominent publications and authors, research themes, and patterns in research production....

Mindfulness-Based Mobile Health to Address Unhealthy Eating Among Middle-Aged Sexual Minority Women With Early Life Adversity: Mixed Methods Feasibility Trial.

Journal of Medical Internet Research September 26, 2023 Shufang Sun, William Nardi, Matthew A Murphy et al.

Background: Sexual minority women (lesbian, gay, bisexual, pansexual, queer, and other nonheterosexual women) remain considerably underrepresented in health research despite being at a higher risk for diabetes and obesity as well as stigma and psychological distress than their heterosexual peers. In addition, early life adversity (ELA) is prevalent among sexual minority women, which further...

A suite of engineered mice for interrogating psychedelic drug actions

bioRxiv (Cold Spring Harbor Laboratory) September 26, 2023 Yi-Ting Chiu, Wei Wang, Pierre Llorach et al. 15 citations preprint

ABSTRACT Psychedelic drugs like lysergic acid diethylamide (LSD) and psilocybin have emerged as potentially transformative therapeutics for many neuropsychiatric diseases, including depression, anxiety, post-traumatic stress disorder, migraine, and cluster headaches. LSD and psilocybin exert their psychedelic effects via activation of the 5-hydroxytryptamine 2A receptor (HTR2A). Here we provide...

Influence of low-dose esketamine on postoperative depressive symptoms in patients with breast cancer (EASE): study protocol for a randomised controlled trial

BMJ Open September 25, 2023 Cen Chen, Qingfeng Wei, Jiajia Zhu et al. 7 citations

Introduction Depressive symptoms have surfaced as the principal mental health concern among patients with breast cancer, with surgical interventions potentially exacerbating these symptoms and adversely influencing clinical outcomes. This study protocol is designed to investigate the efficacy of low-dose esketamine administered perioperatively on depressive symptoms in patients with breast...